Azenta, Inc. (AZTA) Insider Trading Activity
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $57M |
AZTA Insider Trading Activity
AZTA Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $1,307,940 | 6 | 43 |
Sells | $222,739 | 8 | 57 |
Related Transactions
| Marotta John | President and CEO | 2 | $552,904 | 0 | $0 | $552,904 |
| Cornog William L | director | 1 | $495,000 | 0 | $0 | $495,000 |
| Madaus Martin D | director | 1 | $201,404 | 0 | $0 | $201,404 |
| HIRSCH DIDIER | director | 1 | $39,500 | 0 | $0 | $39,500 |
| Zhou Ginger | SVP and General Manager, Genom | 1 | $19,132 | 1 | $19,674 | $-542 |
| Wang David Dong | SVP & GM, SMS | 0 | $0 | 1 | $13,944 | $-13,944 |
| Pirogova Olga | SVP and CHRO | 0 | $0 | 1 | $21,958 | $-21,958 |
| Hughes Violetta | VP, Chief Accounting Officer | 0 | $0 | 2 | $23,323 | $-23,323 |
| Joseph Jason | SVP, General Counsel, Secy. | 0 | $0 | 1 | $45,640 | $-45,640 |
| Cueto Herman | EVP, Chief Financial Officer | 0 | $0 | 2 | $98,199 | $-98,199 |
About Azenta, Inc.
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
Insider Activity of Azenta, Inc.
Over the last 12 months, insiders at Azenta, Inc. have bought $1.31M and sold $222,739 worth of Azenta, Inc. stock.
On average, over the past 5 years, insiders at Azenta, Inc. have bought $1.03M and sold $11.76M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Marotta John (President and CEO) — $552,904. Cornog William L (director) — $495,000. Madaus Martin D (director) — $201,404.
The last purchase of 417 shares for transaction amount of $19,132 was made by Zhou Ginger (SVP and General Manager, Genom) on 2025‑01‑31.
List of Insider Buy and Sell Transactions, Azenta, Inc.
| 2025-02-03 | Sale | Hughes Violetta | VP, Chief Accounting Officer | 317 0.0007% | $52.97 | $16,791 | -29.81% | |
| 2025-01-31 | Zhou Ginger | SVP and General Manager, Genom | 417 0.0008% | $45.88 | $19,132 | -32.25% | ||
| 2024-11-19 | Sale | Joseph Jason | SVP, General Counsel, Secy. | 1,139 0.0023% | $40.07 | $45,640 | +9.91% | |
| 2024-11-19 | Sale | Zhou Ginger | SVP and General Manager, Genom | 491 0.001% | $40.07 | $19,674 | +9.91% | |
| 2024-11-19 | Sale | Wang David Dong | SVP & GM, SMS | 348 0.0007% | $40.07 | $13,944 | +9.91% | |
| 2024-11-19 | Sale | Cueto Herman | EVP, Chief Financial Officer | 712 0.0014% | $40.07 | $28,530 | +9.91% | |
| 2024-11-19 | Sale | Pirogova Olga | SVP and CHRO | 548 0.0011% | $40.07 | $21,958 | +9.91% | |
| 2024-11-19 | Sale | Hughes Violetta | VP, Chief Accounting Officer | 163 0.0003% | $40.07 | $6,531 | +9.91% | |
| 2024-11-19 | Marotta John | President and CEO | 1,250 0.0026% | $40.67 | $50,838 | +9.91% | ||
| 2024-11-19 | Madaus Martin D | director | 4,940 0.0101% | $40.77 | $201,404 | +9.91% | ||
| 2024-11-18 | Marotta John | President and CEO | 12,716.98 0.0254% | $39.48 | $502,066 | +11.30% | ||
| 2024-11-18 | Cornog William L | director | 12,500 0.0251% | $39.60 | $495,000 | +11.30% | ||
| 2024-11-18 | HIRSCH DIDIER | director | 1,000 0.002% | $39.50 | $39,500 | +11.30% | ||
| 2024-10-17 | Sale | Cueto Herman | EVP, Chief Financial Officer | 1,595 0.0033% | $43.68 | $69,670 | +2.30% | |
| 2023-08-11 | Sale | Gray David C | Chief Strategy & New Business | 10,877 0.0166% | $56.03 | $609,438 | -1.44% | |
| 2023-08-10 | Sale | Gray David C | Chief Strategy & New Business | 10,732 0.017% | $57.24 | $614,300 | -0.63% | |
| 2023-06-06 | Sale | MARTIN JOSEPH R | director | 2,400 0.0033% | $43.07 | $103,368 | +19.64% | |
| 2022-08-19 | Robertson Lindon G | EVP & Chief Financial Officer | 4,350 0.0058% | $57.62 | $250,647 | -20.47% | ||
| 2022-08-19 | McManus Matthew | EVP & Chief Operating Officer | 8,625 0.0116% | $58.15 | $501,544 | -20.47% | ||
| 2022-04-12 | Sale | Crowley Kimberly | SVP, Chief HR Officer | 132 0.0002% | $78.02 | $10,299 | -25.53% |
Insider Historical Profitability
| Joseph Jason | SVP, General Counsel, Secy. | 112564 0.2459% | $3.14M | 0 | 44 | |
| Marotta John | President and CEO | 100862 0.2203% | $2.81M | 2 | 0 | |
| Zhou Ginger | SVP and General Manager, Genom | 27916 0.061% | $778,856.40 | 1 | 1 | |
| Wang David Dong | SVP & GM, SMS | 24114 0.0527% | $672,780.60 | 0 | 1 | |
| Cueto Herman | EVP, Chief Financial Officer | 23892 0.0522% | $666,586.80 | 0 | 2 | |
| Pirogova Olga | SVP and CHRO | 19373 0.0423% | $540,506.70 | 0 | 1 | |
| Cornog William L | director | 14755 0.0322% | $411,664.50 | 1 | 0 | |
| Hughes Violetta | VP, Chief Accounting Officer | 9603 0.021% | $267,923.70 | 0 | 2 | |
| Madaus Martin D | director | 7405 0.0162% | $206,599.50 | 1 | 0 | |
| HIRSCH DIDIER | director | 3465 0.0076% | $96,673.50 | 1 | 0 | |
| SCHWARTZ STEPHEN S | CEO | 379354 0.8286% | $10.58M | 0 | 46 | |
| Haris Clinton M. | SVP, Brooks Life Sciences | 160287 0.3501% | $4.47M | 0 | 1 | |
| Tenney Maurice H. | President-Brooks Life Sciences | 136556 0.2983% | $3.81M | 0 | 12 | |
| Mirchandani Kush | SVP, Worldwide Sales | 120792 0.2639% | $3.37M | 0 | 4 | |
| Robertson Lindon G | EVP & Chief Financial Officer | 100571 0.2197% | $2.81M | 2 | 20 | +15% |
| Montone William T. | SVP, Human Resources | 91936 0.2008% | $2.57M | 0 | 44 | |
| MARTIN JOSEPH R | director | 85175 0.1861% | $2.38M | 0 | 7 | |
| WOOLLACOTT ALFRED III | director | 84736 0.1851% | $2.36M | 0 | 2 | |
| Gray David C | Chief Strategy & New Business | 70610 0.1542% | $1.97M | 0 | 27 | |
| ALLEN A CLINTON | director | 69093 0.1509% | $1.93M | 1 | 0 | +46.23% |
| Mathews Timothy S | Principal Accounting Officer | 55846 0.122% | $1.56M | 0 | 1 | |
| Jarzynka David | President, Semi Solutions | 46315 0.1012% | $1.29M | 0 | 18 | |
| McManus Matthew | EVP & Chief Operating Officer | 29467 0.0644% | $822,129.30 | 1 | 0 | <0.0001% |
| Pietrantoni David | Principal Accounting Officer | 27375 0.0598% | $763,762.50 | 0 | 35 | |
| Vacha Robin | SVP, GM BLS-Products | 22932 0.0501% | $639,802.80 | 0 | 3 | |
| Liao Guojuan | President, GENEWIZ | 12827 0.028% | $357,873.30 | 0 | 2 | |
| MCGILLICUDDY JOHN K | director | 9500 0.0208% | $265,050.00 | 0 | 2 | |
| Crowley Kimberly | SVP, Chief HR Officer | 5133 0.0112% | $143,210.70 | 0 | 1 | |
| Rosenblatt Michael | director | 5051 0.011% | $140,922.90 | 0 | 2 | |
| Davis Robyn C | director | 3569 0.0078% | $99,575.10 | 0 | 1 | |
| De Jesus Linda | Chief Commercial Officer, LS | 2721 0.0059% | $75,915.90 | 0 | 1 |
AZTA Institutional Investors: Active Positions
| Increased Positions | 142 | +36.41% | 6M | +11.87% |
| Decreased Positions | 176 | -45.13% | 6M | -11.05% |
| New Positions | 40 | New | 2M | New |
| Sold Out Positions | 59 | Sold Out | 1M | Sold Out |
| Total Postitions | 356 | -8.72% | 51M | +0.82% |
AZTA Ownership Change vs Market
Institutional Investor Ownership
| Blackrock, Inc. | $145,714.00 | 11.75% | 5.4M | -371,718 | -6.43% | 2025-03-31 |
| Politan Capital Management Lp | $124,360.00 | 10.03% | 4.61M | +995 | +0.02% | 2024-12-31 |
| Vanguard Group Inc | $121,735.00 | 9.82% | 4.52M | -160,350 | -3.43% | 2024-12-31 |
| Dimensional Fund Advisors Lp | $81,774.00 | 6.59% | 3.03M | +26,929 | +0.9% | 2024-12-31 |
| Kayne Anderson Rudnick Investment Management Llc | $60,336.00 | 4.87% | 2.24M | -42,022 | -1.84% | 2024-12-31 |
| Conestoga Capital Advisors, Llc | $51,643.00 | 4.16% | 1.92M | +337,675 | +21.4% | 2025-03-31 |
| State Street Corp | $47,390.00 | 3.82% | 1.76M | +70,785 | +4.2% | 2024-12-31 |
| Schroder Investment Management Group | $37,880.00 | 3.05% | 1.41M | +447,292 | +46.7% | 2024-12-31 |
| Gw&K Investment Management, Llc | $35,023.00 | 2.82% | 1.3M | -257,794 | -16.56% | 2024-12-31 |
| Macquarie Group Ltd | $28,505.00 | 2.3% | 1.06M | +9,618 | +0.92% | 2024-12-31 |